DBN1

Across TCGA pan-cancer cohorts, DBN1 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated DBN1 data layer compared with 24 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher DBN1 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated DBN1 expression acts as an unfavorable survival marker.

CCRCC, PDAC, and LUAD are the cancer types where DBN1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	DFS	Median	All	0.502	0.922	.002	36	view →
PDAC	OS	Quartile	All	0.281	0.582	.021	5	view →
LUAD	OS	Median	III,IV	0.747	1.000	.002	4	view →
LSCC	DFS	Quartile	III,IV	0.541	1.000	.036	2	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

DBN1–CCRCC (DFS)

Open the CCRCC breakdown →